JOHNSON JOHN Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$43,214.53

Insider Activity of JOHNSON JOHN

According to the SEC Form 4 filings, JOHNSON JOHN, being in a position of

  1. director at AxoGen, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 56429 shares for $1.87M,
    over all time since 2025-06-09, has bought 0 shares, and sold 60502 shares for $1.91M.

Biography of JOHNSON JOHN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,936,8025100

Comparison of Insiders on Amount of Buys and Sells

2026-06-04SaleXeris Biopharma Holdings, Inc.
XERS
director
15,000
0.0086%
$6.09$91,422+38.54%
2026-05-07SaleAxoGen, Inc.
AXGN
director
11,050
0.0207%
$43.26$477,968-1.59%
2025-12-19SaleXeris Biopharma Holdings, Inc.
XERS
director
135,400
0.0802%
$7.22$977,019+0.27%
2025-12-09SaleAxoGen, Inc.
AXGN
director
21,686
0.0462%
$29.98$650,190+27.44%
2025-12-08SaleAxoGen, Inc.
AXGN
director
23,693
0.0523%
$31.24$740,203+25.92%
2025-08-13SaleXeris Biopharma Holdings, Inc.
XERS
director
107,500
0.067%
$7.32$786,459-0.55%
2025-06-09SaleAxoGen, Inc.
AXGN
director
4,073
0.0091%
$10.61$43,215+180.69%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.